Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 9781603, 11 pages
https://doi.org/10.1155/2017/9781603
Research Article

Buparvaquone Nanostructured Lipid Carrier: Development of an Affordable Delivery System for the Treatment of Leishmaniases

1Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo, Professor Lineu Prestes Av 580, Cidade Universitária, 05508-000 São Paulo, SP, Brazil
2Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, 8613 114th St NW, Edmonton, AB, Canada T6G 2H7
3Seroepidemiology, Cellular and Molecular Immunology Laboratory, Institute of Tropical Medicine, University of São Paulo, Dr. Enéas de Carvalho Aguiar 470, Jardim América, 05403-000 São Paulo, SP, Brazil

Correspondence should be addressed to Nádia Bou-Chacra; rb.psu@arcahc

Received 8 September 2016; Accepted 5 January 2017; Published 1 February 2017

Academic Editor: Sanjula Baboota

Copyright © 2017 Lis Marie Monteiro et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Lis Marie Monteiro, Raimar Löbenberg, Paulo Cesar Cotrim, Gabriel Lima Barros de Araujo, and Nádia Bou-Chacra, “Buparvaquone Nanostructured Lipid Carrier: Development of an Affordable Delivery System for the Treatment of Leishmaniases,” BioMed Research International, vol. 2017, Article ID 9781603, 11 pages, 2017. https://doi.org/10.1155/2017/9781603.